Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

ISIN: IT0003828271 | Ticker: REC | LEI: 815600FBF92FD3531704
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Italy

About Recordati Industria Chimica e Farmaceutica

Company Description

Recordati is a well-established international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals with more than 4,300 employees listed on the Italian Stock Exchange since 1984. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, in Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia.

Recordati offers a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized segment dedicated to treatments for rare diseases. An efficient field force of medical representatives and orphan drug representatives promotes its products in about 150 markets.

Served area

Worldwide

Headcount

4,300

Headquarters

Via M. Civitali 1, 20148 Milano – Italy

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 02.01.2021 01.01.2022 02.01.2022 01.01.2023
Assets N/A 2,711,654,000.00 N/A 2,816,199,000.00 N/A 3,998,823,000.00
Noncurrent Assets N/A 1,938,703,000.00 N/A 1,966,098,000.00 N/A 2,812,736,000.00
Goodwill N/A 562,116,000.00 N/A 553,209,000.00 N/A 780,057,000.00
Intangible Assets Other Than Goodwill N/A 1,115,811,000.00 N/A 1,138,786,000.00 N/A 1,758,173,000.00
Deferred Tax Assets N/A 75,084,000.00 N/A 75,922,000.00 N/A 76,895,000.00
Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income N/A 45,581,000.00 N/A 34,124,000.00 N/A 28,871,000.00
Other Noncurrent Assets N/A 6,861,000.00 N/A 32,937,000.00 N/A 9,556,000.00
Current Assets N/A 772,951,000.00 N/A 850,101,000.00 N/A 1,173,617,000.00
Current Trade Receivables N/A 268,897,000.00 N/A 307,778,000.00 N/A 361,898,000.00
Other Current Receivables N/A 47,291,000.00 N/A 44,880,000.00 N/A 63,915,000.00
Cash and cash equivalents 187,923,000.00 188,230,000.00 188,230,000.00 244,578,000.00 244,578,000.00 284,734,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Distribution To Owners N/A N/A N/A 0.00 N/A 12,470,000.00
Other Current Assets N/A 10,245,000.00 N/A 12,984,000.00 N/A 15,387,000.00
Equity And Liabilities N/A 2,711,654,000.00 N/A 2,816,199,000.00 N/A 3,998,823,000.00
Equity 1,198,811,000.00 1,276,260,000.00 N/A 1,381,625,000.00 N/A 1,546,248,000.00
Issued Capital N/A 26,141,000.00 N/A 26,141,000.00 N/A 26,141,000.00
Retained Earnings N/A 1,151,053,000.00 N/A 1,275,962,000.00 N/A N/A
Retained Earnings Profit Loss For Reporting Period N/A N/A N/A 385,966,000.00 N/A 312,336,000.00
Retained Earnings Excluding Profit Loss For Reporting Period N/A N/A N/A 1,275,962,000.00 N/A 1,524,099,000.00
Share Premium N/A 83,719,000.00 N/A 83,719,000.00 N/A 83,719,000.00
Treasury Shares N/A 87,516,000.00 N/A 126,981,000.00 N/A 149,559,000.00
Other Reserves N/A 70,707,000.00 N/A 60,207,000.00 N/A 62,260,000.00
Equity Attributable To Owners Of Parent N/A 1,275,983,000.00 N/A 1,381,625,000.00 N/A 1,546,248,000.00
Noncontrolling Interests N/A 277,000.00 N/A 0.00 N/A 0.00
Noncurrent Liabilities N/A 856,930,000.00 N/A 808,158,000.00 N/A 1,528,832,000.00
Noncurrent Provisions For Employee Benefits N/A 21,174,000.00 N/A 21,010,000.00 N/A 19,418,000.00
Other Noncurrent Payables N/A 16,299,000.00 N/A 0.00 N/A N/A
Deferred Tax Liabilities N/A 41,219,000.00 N/A 26,675,000.00 N/A 167,865,000.00
Current Liabilities N/A 578,464,000.00 N/A 626,416,000.00 N/A 923,743,000.00
Current Provisions N/A 17,113,000.00 N/A 21,396,000.00 N/A 16,209,000.00
Trade And Other Current Payables To Trade Suppliers N/A 132,096,000.00 N/A 177,925,000.00 N/A 224,703,000.00
Other Current Payables N/A 95,671,000.00 N/A 145,170,000.00 N/A 251,136,000.00
Current Tax Liabilities Current N/A 29,743,000.00 N/A 29,543,000.00 N/A 33,615,000.00
Other Current Financial Liabilities N/A 12,567,000.00 N/A 8,657,000.00 N/A 83,425,000.00
Other Current Liabilities N/A 11,250,000.00 N/A 6,508,000.00 N/A 5,740,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
31.12.2021/
01.01.2022
31.12.2022/
01.01.2023
Revenue 1,448,867,000.00 1,580,074,000.00 1,580,074,000.00 1,853,307,000.00
Profit Loss From Operating Activities 469,016,000.00 490,190,000.00 490,190,000.00 437,326,000.00
Profit Loss Before Tax 455,656,000.00 463,349,000.00 463,349,000.00 401,435,000.00
Income Tax Expense Continuing Operations 100,629,000.00 77,383,000.00 77,383,000.00 89,099,000.00
Profit (loss) 355,027,000.00 385,966,000.00 385,966,000.00 312,336,000.00
Profit Loss Attributable To Owners Of Parent 354,984,000.00 385,966,000.00 385,966,000.00 312,336,000.00
Profit Loss Attributable To Noncontrolling Interests 43,000.00 0.00 0.00 0.00
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 02.01.2021 02.01.2022 01.01.2023
Profit (loss) N/A 355,027,000.00 385,966,000.00 N/A N/A 312,336,000.00
Adjustments For Income Tax Expense N/A 100,629,000.00 77,383,000.00 N/A N/A 89,101,000.00
Adjustments For Decrease Increase In Inventories N/A 42,924,000.00 -17,506,000.00 N/A N/A 65,801,000.00
Adjustments For Increase Decrease In Trade Account Payable N/A 38,614,000.00 -46,335,000.00 N/A N/A -25,589,000.00
Adjustments For Sharebased Payments N/A 4,878,000.00 5,082,000.00 N/A N/A 8,251,000.00
Other Adjustments For Noncash Items N/A 1,997,000.00 12,925,000.00 N/A N/A 70,751,000.00
Interest Paid Classified As Operating Activities N/A -18,699,000.00 -18,279,000.00 N/A N/A -20,093,000.00
Interest Received Classified As Operating Activities N/A 463,000.00 291,000.00 N/A N/A 1,938,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A -65,272,000.00 -91,646,000.00 N/A N/A -89,764,000.00
Cash Flows From Used In Operating Activities N/A 403,575,000.00 491,650,000.00 N/A N/A 461,691,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 66,000.00 0.00 N/A N/A N/A
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 0.00 304,000.00 N/A N/A 673,259,000.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 0.00 161,000.00 N/A N/A 1,156,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 21,263,000.00 21,852,000.00 N/A N/A 23,887,000.00
Proceeds From Sales Of Intangible Assets Classified As Investing Activities N/A 57,000.00 4,000.00 N/A N/A 1,318,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 110,415,000.00 65,508,000.00 N/A N/A 72,452,000.00
Cash Flows From Used In Investing Activities N/A -131,555,000.00 -87,499,000.00 N/A N/A -767,124,000.00
Payments To Acquire Or Redeem Entitys Shares N/A 47,871,000.00 101,820,000.00 N/A N/A 52,267,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 9,730,000.00 9,153,000.00 N/A N/A 10,225,000.00
Dividends Paid Classified As Financing Activities N/A 212,718,000.00 216,742,000.00 N/A N/A 230,602,000.00
Cash Flows From Used In Financing Activities N/A -264,288,000.00 -355,943,000.00 N/A N/A 341,277,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -7,425,000.00 7,661,000.00 N/A N/A 4,312,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 7,732,000.00 48,208,000.00 N/A N/A 35,844,000.00
Cash and cash equivalents 187,923,000.00 188,230,000.00 244,578,000.00 188,230,000.00 244,578,000.00 284,734,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ITA / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

IT0003828271

LEI

815600FBF92FD3531704

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Borsa Italiana

Stock Index

FTSE MIB

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.